Is NewAmsterdam Pharma Company N.V. (NAMS) a Buy, Sell, or Hold?
NewAmsterdam Pharma Company N.V.
NASDAQ:NAMS
$31.98 USD
-$1.31 (-3.94%)
- Volume
- 1.03M
- Average Volume
- 1.3M
- Market Capitalization
- $3.74B
- P/E Ratio
- -17.67
- Dividend Yield
- 0.00%
- Price Target
- $48.00
- Year High
- $42.21
- Year Low
- $20.53
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.76
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-33.4% DOWNSIDE
$48.00 Price Target
UPSIDE/DOWNSIDE HIGH
-37.3% DOWNSIDE
$51.00 Price Target High
UPSIDE/DOWNSIDE LOW
-28.9% DOWNSIDE
$45.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Leerink Partners | Roanna Ruiz | $55 | $33.48 | 2026-01-06 04:33 AM | 64.3% |
| H.C. Wainwright | Joseph Pantginis | $52 | $36.4 | 2025-10-20 06:16 AM | 42.9% |
| H.C. Wainwright | Ed Arce | $48 | $25.6 | 2024-12-30 06:11 AM | 87.5% |
| Leerink Partners | Roanna Ruiz | $45 | $20.01 | 2024-11-20 04:10 PM | 124.9% |